Next Article in Journal
Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs)
Previous Article in Journal
Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”
 
 
Systematic Review

Article Versions Notes

Medicina 2022, 58(6), 792; https://doi.org/10.3390/medicina58060792
Action Date Notes Link
article xml file uploaded 13 June 2022 09:46 CEST Original file -
article xml uploaded. 13 June 2022 09:46 CEST Update -
article pdf uploaded. 13 June 2022 09:46 CEST Version of Record https://www.mdpi.com/1648-9144/58/6/792/pdf
article supplementary file uploaded. 13 June 2022 09:46 CEST - https://www.mdpi.com/1648-9144/58/6/792#supplementary
article html file updated 13 June 2022 09:48 CEST Original file -
article xml uploaded. 15 July 2022 03:10 CEST Update https://www.mdpi.com/1648-9144/58/6/792/xml
article html file updated 15 July 2022 03:11 CEST Update -
article html file updated 12 August 2022 20:04 CEST Update -
article html file updated 15 May 2023 13:53 CEST Update https://www.mdpi.com/1648-9144/58/6/792/html
Back to TopTop